1. Two Faces of Vitamin C in Hemodialysis Patients: Relation to Oxidative Stress and Inflammation.
- Author
-
Chaghouri P, Maalouf N, Peters SL, Nowak PJ, Peczek K, Zasowska-Nowak A, and Nowicki M
- Subjects
- Ascorbic Acid administration & dosage, Humans, Vitamins administration & dosage, Ascorbic Acid pharmacology, Inflammation, Oxidative Stress, Renal Dialysis, Vitamins pharmacology
- Abstract
Hemodialysis (HD) is the most common method of renal replacement therapy. Besides toxins, it eliminates nutrients from the circulation, such as ascorbic acid (AA). HD-patients present AA deficiency more often than representatives of the general population, also due to dietary restrictions. This condition aggravates oxidative stress and inflammation related to uremia and extracorporeal circulation and increases cardiovascular risk followed by mortality. Supplementation of AA seems to be a promising approach in the treatment of hemodialysis patients. Many successful interventions restored plasma AA concentration in HD patients by enteral or intravenous supplementation, concomitantly inhibiting oxidative stress and inflammation. A significant number of studies reported opposite, serious pro-oxidant effects of AA. In this narrative review, we present studies, commenting on their limitations; on AA plasma or serum concentration and the influence of its supplementation on protein and lipid peroxidation, DNA damage, reactive oxygen species generation, paraoxonase activity, advanced glycation endproducts, and C-reactive protein (CRP) concentration. Moreover, in terms of safety, the possible development of oxalosis in HD patients regarding the intravenous or enteral route of AA administration is discussed. Unequivocal clinical results of recent studies on hemodialysis patients are displayed.
- Published
- 2021
- Full Text
- View/download PDF